Oncology News, Insights, Stories by OncoDaily

EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary sAML
2025-04-25 08:00 - 2025-04-26 17:00 (Europe/Berlin) | Berlin, Berlin, Germany
EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary AMLs will be held April 25-26, 2025 at Berlin, Germany.
The EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias (sAML) will focus on therapy-related AML and AML evolving from previous myeloid diseases, such as MDS or MFS/MPN. Key topics will include clonal hematopoiesis, clonal evolution mechanisms, and special clinical situations.
The program will cover pathogenetic mechanisms, including susceptibility factors like molecular lesions, the bone marrow microenvironment, and the impact of drugs. Special topics include sAML following childhood malignancies, gene therapy, CAR-T cell therapy, and AML of donor origin in allogeneic stem cell transplantation. The meeting will feature leading experts in sAML molecular characterization, disease diagnosis, management, and treatment. The event will be chaired by K. Döhner, P. Vyas, and M.T. Voso.
Registration is open.

Acute Lymphoblastic Leukemia - Strategies to reduce relapse risk in low resource settings webinar by SIOP
2025-04-24 19:00 - 20:30 (Asia/Yerevan)
Acute Lymphoblastic Leukemia- Strategies to reduce relapse risk in low resource settings webinar by SIOP will be held on April 24, 2025, Virtually.
The SIOP Global Health Network (GHN) is hosting an educational session through its new initiative, the Disease-Specific Portal for Learning and Networking (DiSPLeN). This platform offers SIOP members valuable learning opportunities focused on various aspects of pediatric cancer care, including case discussions, diagnostic and referral pathways, access to care, and advanced therapies. The initiative supports the goals of the WHO Global Initiative for Childhood Cancer, particularly its focus on the six indexed cancers.
This session will be moderated by Jelena Lazic (Serbia) and Kirril Kirgizov (Russia), featuring a case presentation by Jovana Kostadinovic (Serbia). Invited speakers Martin Schrappe (Germany) and Cesar Nunez (USA) will provide expert commentary and insights. Through DiSPLeN, SIOP GHN aims to foster collaborative learning and strengthen global pediatric oncology care.
Registration is open for the event.

The BSMO Webinar on Toxicity management with ADCs in solid tumours
2025-04-24 19:00 - 20:30 (America/Halifax)
The BSMO Webinar on Toxicity management with ADCs in solid tumours will be held at April 24, 2025.
The BSMO Webinar on Toxicity Management with ADCs in Solid Tumours will focus on the management of various toxicities associated with Antibody-Drug Conjugates (ADCs) in solid tumours, such as breast, lung, and gastric cancer. The Webinar will be chaired by Evandro de Azambuja and Kevin Punie.
The topics covered will include the management of haematological toxicities caused by ADCs, as well as strategies for addressing gastro-intestinal toxicities related to ADC treatments. The webinar will also focus on preventing and managing interstitial lung disease (ILD) caused by ADCs. Additionally, it will discuss approaches for dealing with common side effects such as fatigue and alopecia.
Registration is open.

The ENTERO Policy Event by Digestive Cancers Europe
2025-04-24 09:30 - 12:00 (Europe/Brussels) | European Parliament, Brussels, Rue Wiertz 60, 1050 Ixelles, Brussels, Belgium
The ENTERO Policy Event by Digestive Cancers Europe will be held on April 24th, 2025 at the European Parliament, Belgium.
The ENTERO Policy Event, organized by Digestive Cancers Europe (DiCE) and co-hosted by Romana Jerkovic and Vytenis Povilas Andriukaitis, will address the rise of early-age onset digestive cancers affecting individuals under 50. The event aims to raise awareness, improve early detection, and enhance care through discussions with patients, healthcare professionals, researchers, and policymakers. Prof. Eric Van Cutsem and Vytenis Povilas Andriukaitis will deliver the closing remarks.
Registration is open for the event.

From policy frameworks to real-world implementation: a call to action by SPCC
2025-04-16 08:00 - 17:00 (America/Halifax)
From policy frameworks to real-world implementation: a call to action by SPCC will be held on April 16, 2025, Virtually.
This comprehensive course includes three educational modules and a live interactive webinar, focusing on key opportunities, challenges, and best practices in Data Policy and Management in Cancer Care.
Expert speakers for the course include Pisani Eduardo, Presti Pietro, Garcia-Foncillas López Jesús, Hickey Matt, and Saunders Christobel, who will share their insights on navigating the complexities of cancer care, optimizing data management, and improving patient outcomes through innovative strategies. This training provides a valuable opportunity for professionals to enhance their skills and understanding in this critical area of cancer care.

The Essential Medicines for Children with Cancer: From Access to Action by OncoDaily
2025-04-15 08:00 - 11:00 (America/Halifax)
The Essential Medicines for Children with Cancer: From Access to Action OncoDaily Virtual Forum will be held on April 15, 2025 from 8 to 11 AM EST.
The Forum will focus on the WHO Essential Medicines List for Children, the new applications including Blinatumomab and Temozolomide, the challenges different low- and middle-income countries (LMICs) are facing with the access to medications and the role of initiatives such as ACT4Children and the Global Platform for Access to Childhood Cancer Medicines (GPACCM).
Speakers will include Guillermo Chantada, Andre Ilbawi, Scott Howard, Roberto Vasquez, Gilles Vassal, Manette Le Grange, Yizhou Zhang, Anna Avagyan.
Moderators of the event are Gevorg Tamamyan and Shushan Hovsepyan.
The Registration Form of the event.
Read further to Find the Agenda and More Information about the “Essential Medicines for Children with Cancer: From Access to Action OncoDaily Virtual Forum”.

The Breast Cancer Symposium 2025
2025-04-12 08:00 - 17:00 (America/Halifax) | Detroit, Marriott, 200 W. Big Beaver Road Troy, 48084, United States
The Breast Cancer Symposium 2025 will be held on April 12,2025 at Detroit, USA.
The Breast Cancer Symposium 2025, presented by the Barbara Ann Karmanos Cancer Institute and Wayne State University, is designed for healthcare professionals in hematology and oncology, including physicians, surgeons, fellows, residents, pathologists etc.
This annual conference will cover the latest advancements in breast cancer treatment, including updates on HER2+ Breast Cancer, Breast Reconstruction, and an Overview of Anthracycline Use in Breast Cancer. Attendees will gain insights into the multimodal care of breast cancer patients and the evolving strategies in treating these cancers.
The symposium will focus on integrating diagnostic and therapeutic strategies in the treatment of breast cancer, particularly through the use of both cytotoxic and biologic agents. Participants will also have the opportunity to explore the latest research findings and how these developments can impact future decisions in the diagnosis and treatment of breast cancer. This conference will provide a comprehensive learning experience for healthcare professionals, keeping them up-to-date with the most recent and relevant information in the field.
Registration is open for the event until April 10, 2025.

SIOP Asia 2025
2025-04-12 07:00 - 2025-04-15 03:30 (Atlantic/Azores) | Riyadh, Riyadh, 11564, Saudi Arabia
SIOP Asia 2025 will take place in Riyadh from April 12-15, 2025.
It will bring together experts in pediatric oncology to foster collaboration and improve outcomes for children with cancer. This event is a platform for shared learning, innovation, and partnership, advancing the field of pediatric oncology.
The theme of the 19th Annual SIOP Asia Congress, “Stronger Together,” emphasizes the power of collaboration and collective effort in the fight against pediatric cancer. This theme underscores the importance of working in partnership—across borders, disciplines, and organizations—to improve treatment outcomes and support children with cancer worldwide.
Submit Your Abstract Here

Texas Lung Cancer Conference 2025
2025-04-10 00:00 - 2025-04-12 00:00 (America/Halifax) | Moody Theater, 310 W Willie Nelson Blvd, Austin, TX 78701
Texas Lung Cancer Conference 2025 will be held from April 10-12, 2025 at Austin, Texas.
The 3rd Annual Texas Lung Cancer Conference will be held at ACL Live at the Moody Theater in Austin, Texas, offering a 2-day continuing education experience for oncologists and cancer care providers. Jointly provided by the Postgraduate Institute for Medicine and IDEOlogy, the conference will cover the latest advancements in lung cancer care, focusing on immunotherapy, targeted therapies, and innovative treatment approaches. Topics will range from foundational concepts like NGS (Next-Generation Sequencing) to advanced discussions on selecting the best first-line therapy for EGFR mutant NSCLC.
This event is co-chaired by Drs. Stephen V Liu and Tina Cascone and it will feature a distinguished group of lung cancer experts who will share their knowledge through focused talks, interactive panel discussions, and live Q and A sessions. The conference will not only provide insights into existing data but also give participants the chance to understand the rationale behind key clinical trials and effective patient care strategies.
Registration is Open.

I Central Asian Forum on Lung Cancer: Current Issues in Diagnosis and Treatment of Lung Cancer
2025-04-08 00:00 - 2025-04-09 00:00 (Asia/Almaty) | National Academy of Sciences of the Republic of Kazakhstan, Shevchenko St., 28, Almaty, Almaty, Kazakhstan
Kazakhstan Cancer Society invites you to participate in the International Conference “I Central Asian Forum on Lung Cancer: Current Issues in Diagnosis and Treatment of Lung Cancer”, dedicated to the 95th anniversary of the Kazakh National Medical University named after S.D. Asfendiyarov, which will be held on April 8-9, 2025, in Almaty, Kazakhstan.
The conference will focus on current issues of early detection, diagnosis, and treatment of lung cancer. The event is expected to bring together over 300 specialists, providing an excellent platform for professional networking and knowledge exchange. Hosted at the National Academy of Sciences of the Republic of Kazakhstan, the conference will be held in a hybrid format, allowing both local and international participants to join in-person or online.
Follow the link for Registration.

Tackling oncology inequalities: Addressing social drivers of health in LMICs and Africa by SPCC
2025-04-07 13:00 - 17:00 (America/Halifax)
Tackling oncology inequalities: addressing social drivers of health in LMICs and Africa by SPCC will be held on April 7th, 2025, Virtually.
The event organized by SPCC focuses on the urgent need for health equity in cancer care, particularly in low- and middle-income countries (LMICs) and Africa. It will address the impact of social determinants like socioeconomic status, race, and access to healthcare on cancer outcomes. The discussion will emphasize the importance of overcoming these barriers, expanding access to treatment, and ensuring equal care for all patients, regardless of background.
Speakers at the event, including Keefe Dorothy, Ibraheem Abiola, and Ilbawi André, will share insights on tackling these inequalities, advocating for strategies that promote health equity in oncology and improve outcomes for marginalized populations.
Read more about SPCC at OncoDaily.com.

Comprehensive Quality Management in Radiotherapy: Quality Assessment and Improvement by ESTRO
2025-04-06 08:00 - 2025-04-09 17:00 (Europe/Athens) | Titania Hotel Athens, 52, Panepistimiou, Athens, 10678, Greece
Comprehensive Quality Management in Radiotherapy: Quality Assessment and Improvement by ESTRO will be held from April 6-9, 2025 at Athens, Greece.
The “Comprehensive Quality Management in Radiotherapy: Quality Assessment and Improvement” course, organized by ESTRO, is designed for radiation oncologists, medical physicists, radiation therapists, and hospital administrators. The course emphasizes the importance of quality in radiotherapy, offering practical strategies to set up effective quality systems, define key indicators, and enhance patient safety and treatment efficiency. Aimed at leaders and future leaders, the course aims to foster a culture of quality in radiotherapy departments and increase the number of quality champions within the field.

ASPO 49th Annual Meeting
2025-04-06 00:00 - 2025-04-08 00:00 (America/Halifax) | Loews, 1200 Market St, Philadelphia, PA 19107, Philadelphia, PA, 19107, United States
ASPO 49th Annual Meeting 2025 will take place at the Loews Philadelphia on April 6-8.
The 2025 Program Committee is excited to unveil the dynamic agenda for the upcoming Annual Meeting, designed to offer a rich and engaging learning experience. Attendees can look forward to four symposia and four ‘Looking Back, Thinking Forward’ sessions.
Additionally, the ‘Best of ASPO’ sessions will highlight 32 top-ranking abstracts, each presented in 15-minute oral presentations, showcasing cutting-edge research and fostering thought-provoking conversations. This meeting promises to be an inspiring blend of knowledge sharing and collaboration.

The 3rd International Liver Days, Single Topic Symposium
2025-04-05 08:00 - 18:00 (Europe/Istanbul) | Bahçeşehir University, Ihlamur Yıldız Caddesi 8, Istanbul, 34022, Turkey
The 3rd International Liver Days, Single Topic Symposium will be held on April 5th, 2025 at Bahçeşehir University.
The Conference will focus on a wide range of liver-related topics. Experts in the field will discuss gastroenterological evaluations, current treatment methods, new surgical techniques, and advancements in organ transplantation. The event will also feature multidisciplinary discussions and case presentations, covering key areas such as liver transplant and oncology.
Registration is open for the event.

Highlights of ASH 2025 in the Mediterranean, Middle East, and North Africa
2025-04-04 08:00 - 2025-04-05 17:00 (Europe/Paris) | Hyatt Regency Casablanca in Morocco, Place des Nations Unies, Casablanca, Casablanca, 20000, Morocco
The Highlights of ASH in the Mediterranean, Middle East, and North Africa conference, taking place on April 4-5, 2025, at the Hyatt Regency Casablanca in Morocco.
It will feature a comprehensive two-day program focusing on the most impactful research presented at the latest ASH (American Society of Hematology) annual meeting. This premier event in both malignant and non-malignant hematology will offer participants valuable insights into the latest scientific advancements in clinical and translational hematologic research.
By attending, participants will gain an in-depth understanding of the latest updates in hematology, discover how new research can be directly applied to improve patient care, and engage in thought-provoking interactive discussions. The conference will also provide an opportunity to network with experts, peers, and exhibitors in a collaborative environment, enhancing both personal and professional connections.
Attendees will have access to a curated program featuring key highlights from the ASH annual meeting, providing them with an overview of the most significant and current topics in hematology. Small group lunch sessions and interactive panels with renowned experts will allow for deep dives into the most pressing issues in the field. This event will be an invaluable opportunity for anyone involved in the study and practice of hematology to stay ahead of the latest advancements and trends.
The Program Co-Chairs for the Highlights of ASH in the Mediterranean, Middle East, and North Africa conference include Dr. M’hamed Harif and Dr. Nisrine Khoubila from the Société Marocaine d’Hématologie, and Dr. Jorge Cortes and Dr. Kevin Kuo from the American Society of Hematology.
The Registration for the Program is already open.

Evolving Professions within the Multidisciplinary Cancer Care Team
2025-04-03 15:00 - 16:30 (America/Halifax)
Evolving Professions within the Multidisciplinary Cancer Care Team will be held on April 3rd, 2025, Virtually.
The roundtable event “Evolving Professions within the Multidisciplinary Cancer Care Team” will focus on the vital role of collaboration in cancer care, from diagnosis to treatment. Early career medical physicists from EFOMP will highlight their contributions and discuss the teamwork required with various professionals. The event will explore the challenges and benefits of multidisciplinary care and the development of young professionals in the field. Don’t miss the Q and A session at the end to engage with experts and share your insights.
Registration is open for the event.

Multidisciplinary Management of Breast Cancer by ESTRO
2025-04-03 09:00 - 2025-04-06 12:30 (Europe/Istanbul) | Radisson Blu Hotel Istanbul Sisli, 19 Mayis Caddesi, Istanbul, 34360, Turkey
Multidisciplinary Management of Breast Cancer by ESTRO will be held from April 03-06, 2025 at Istanbul, Turkey and Virtually.
This course is designed for specialists and trainees in radiation and clinical oncology, including doctors, physicists, radiation therapists, breast nurses, and researchers, with an interest in advancing their knowledge of breast cancer management. It encourages a multidisciplinary approach to treatment, focusing on personalized care based on clinical presentation, prognostic factors, and patient needs, while emphasizing shared decision-making.
By the end of the course, participants will be able to understand the epidemiology, clinical, and biological aspects of breast cancer, recognize different prognostic factors and tumor subtypes, and interpret multimodality treatment results. Topics include primary and axillary surgery, modern radiation therapy techniques, re-irradiation, fractionation schedules, emerging treatments like particle therapy, interactions between systemic treatment and radiation, and the management of DCIS and locally advanced disease.

5th How to Diagnose and Treat: Multiple Myeloma by ESH
2025-04-03 00:00 - 2025-04-05 00:00 (Europe/Helsinki) | Austria Trend Hotel Savoyen, Rennweg 16, Vienna, 1030, Austria
5th How to Diagnose and Treat: Multiple Myeloma will be held at Vienna Austria from April 3-5, 2025.
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.
The 5th How to Diagnose and Treat: Multiple Myeloma is committed to providing unbiased, balanced and objective educational and scientific programmes.
For Registration Visit Here

How to implement efficiency in Cancer Care by SPCC
2025-04-01 08:00 - 17:00 (America/Halifax)
“Efficiency implementation in the cancer care continuum: data, metrics and best practices by SPCC” course includes three educational modules.
“How to implement efficiency in Cancer Care by SPCC” is one of the modules that will be held on April 1st, 2025, Virtually.
The event will address key challenges, opportunities, and best practices in managing cancer-related data, aiming to improve patient outcomes and streamline care delivery.
The event will feature expert speakers, including Pisani Eduardo, Bowers Liora, Garcia-Foncillas López Jesús, and Normanno Nicola, who will provide valuable insights and practical strategies for navigating the complexities of cancer care. This collaboration offers professionals an opportunity to deepen their understanding of cancer care management and learn how to implement data-driven approaches to enhance treatment and patient care in an ever-evolving healthcare landscape.

The NANETS Regional NET Education Conference
2025-03-29 07:30 - 15:30 (America/Halifax) | Banner – University Medical Center Tucson, 1625 N Campbell Ave, Tucson, Tucson, AZ, United States
The NANETS Regional NET Education Conference will be held on March 29th, 2025, at Banner – University Medical Center Tucson.
The NANETS Regional NET Education Conference is aimed at doctoral-level healthcare professionals, allied health professionals, pharmaceutical employees, students, fellows, and residents. The conference offers a unique opportunity to enhance knowledge about neuroendocrine tumors (NETs), with a focus on the latest research, clinical practices, and treatment strategies. Attendees will also have the chance to connect with a diverse group of professionals, fostering collaboration and advancing understanding within the neuroendocrine tumor community.
Registration is open until March 21st.

The NCCN 2025 Annual Conference
2025-03-28 07:30 - 2025-03-30 12:30 (America/Halifax) | Caribe Royale Orlando, 8101 World Center Dr, Orlando, Florida, Orlando, 32821, United States
The NCCN 2025 Annual Conference will be held from March 28-March 30, 2025 at Caribe Royale Orlando.
The NCCN 2025 Annual Conference will provide a platform for connection, inspiration, and innovation, focusing on the practical management of cancer patients and best practices for cancer care delivery. Attendees will have the opportunity to network with oncology professionals, engage with experts in small groups, explore research posters, and celebrate NCCN’s 30th anniversary, all while enjoying a beautiful and welcoming environment.
Registration is open until March 3.

Improving cancer outcomes and leadership course: a European initiative by ESO
2025-03-27 00:00 - 2025-03-31 00:00 (Europe/Helsinki) | Zagreb, Zagreb, Croatia (Local Name: Hrvatska)
Improving cancer outcomes and leadership course: a European initiative will be held from March 27 – May 11, 2025.
The Improving Cancer Outcomes and Leadership course by ESO will aim to address disparities in cancer outcomes across Europe. It will equip mid-career healthcare professionals, industry experts, and patient advocates with essential skills in strategic planning, health research, and change management to enhance care quality. The program will focus on early diagnosis, multidisciplinary care, patient-centered approaches, and emphasize the importance of research and clinical trials. Participants from various European countries will be encouraged to form a network for sharing best practices and improving clinical practice in their regions.
For registration visit here

Sleep Needs of Childhood Cancer Patients by SIOP GHN Psychosocial Wellbeing WG
2025-03-26 15:00 - 17:00 (America/Sao_Paulo)
Sleep Needs of Childhood Cancer Patients by SIOP GHN Psychosocial Wellbeing WG will be held on March 26, 2025, Virtually.
The Sleep Needs of Childhood Cancer Patients webinar, organized by the SIOP GHN Psychosocial Wellbeing WG, will focus on the increased risk of sleep disturbances in children and adolescents with cancer. This population faces sleep challenges due to illness-related factors, treatment-induced symptoms, psychological and emotional issues, and environmental disruptions. Most existing interventions to address sleep problems have been validated in healthy children, not specifically those with cancer. The session will discuss tailored interventions at both the individual and environmental levels to better address the unique sleep needs of young cancer patients.
Online registration is available until March 26, 2025.

European Lung Cancer Congress 2025
2025-03-26 11:00 - 2025-03-29 14:00 (Europe/Helsinki) | Paris Expo Porte de Versailles, 2 Pl. de la Prte de Versailles, Paris, 92170, France
The European Lung Cancer Congress 2025 will be held in Paris, France, on March 26-29, 2025, with an online option available through the LIVE Plus format.
This congress unites leading specialists in thoracic oncology—medical oncologists, radiation oncologists, thoracic surgeons, and more—to share knowledge and improve lung cancer care. Attendees can look forward to a dynamic program filled with valuable insights and networking opportunities. The event is organized by the European Society for Medical Oncology and the International Association for the Study of Lung Cancer.
Registration is still open for the event.
Find more information featuring ELCC2024 at OncoDaily.com.

Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM)
2025-03-25 00:00 - 2025-03-29 00:00 (Europe/Helsinki)
Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) will be held from March 25, 2025 – May 29, 2026. It’s a hybrid event and the offline venues will change either.
The Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) is a joint collaboration between the European School of Oncology (ESO) and the University of Fribourg, Switzerland. The programme will focus on the improvement on both the clinical and the scientific aspects of improving quality in the management of patients with lung cancer and other thoracic malignancies. Upon successful completion of the programme, participants will obtain an academic certificate assigning 14 ECTS credits, equalling a work load of 420 hours and a diploma supplement by the University of Fribourg.

Informal meeting of health ministers
2025-03-24 08:00 - 2025-03-25 17:00 (Europe/Warsaw) | Warsaw, Poland, Warsaw, Poland
Informal meeting of health ministers will be held from March 24-25, 2025 at Warsaw, Poland.
While official Council meetings are organized by the Council of the EU and chaired by the Council presidency, each presidency also arranges informal gatherings of ministers to discuss specific initiatives or topics relevant to their area of focus. This meeting will provide a platform for health ministers to exchange views and collaborate on key health-related initiatives within the EU.

The ESTRO Particle Therapy Course
2025-03-23 10:00 - 2025-03-27 12:30 (America/Sao_Paulo)
The ESTRO Particle Therapy Course will be held from March 23-27, 2025 at Maastricht, The Netherlands.
This course is designed for radiation oncologists, medical physicists, and professionals in related fields, including trainees, who are interested in particle therapy. It is aimed at individuals with a basic understanding of radiation oncology and radiation physics. Participants who are currently involved in clinical particle therapy projects, practice particle therapy, or wish to update their knowledge in this area will benefit from the course. The content covers fundamental and advanced topics in particle therapy, equipping participants with the necessary knowledge to enhance their expertise and practice in this specialized field of radiation treatment.

A key part of the program includes guidance on how to develop a particle therapy facility, from project planning to starting clinical operations, as well as expanding existing radiotherapy departments to include particle therapy. A guided tour of a local particle therapy facility will provide a real-world perspective on the implementation of the techniques discussed. Participants are required to have a basic understanding of radiobiology, radiation physics, and radiotherapy planning before attending the course.

Early date for Registration is January 10.

The EAU 2025 Congress
2025-03-21 08:00 - 2025-03-24 16:30 (Europe/Madrid) | IFEMA Madrid, Avda. del Partenón, 5, Madrid, Spain
The EAU 2025 Congress will be held from March 21-24, 2025 at Madrid, Spain.
The 40th Annual EAU Congress is Europe’s premier event in urology, gathering specialists and medical professionals from around the world to evaluate and discuss the latest clinical practices and research advancements. The congress offers a variety of educational formats, including state-of-the-art lectures, HD video surgery sessions, hands-on training, and practical courses aimed at enhancing skills. As the largest and most influential gathering in urology, the event continues its four-decade tradition of presenting cutting-edge science and fostering collaboration among global urological experts.
Registration is open for the event.

Refresher course for diagnosis and management of early-stage lung cancer by ESO
2025-03-20 18:00 - 2025-03-22 12:00 (America/Sao_Paulo) | Belgrade, Belgrade, Serbia
Refresher course for diagnosis and management of early-stage lung cancer by ESO will be held at Belgrade, Serbia from March 20-22, 2025.
This course is designed to provide a comprehensive understanding of the latest diagnostic and therapeutic approaches in the diagnosis and management of early-stage lung cancer. The primary goal is to enhance multidisciplinary collaboration between respiratory physicians, thoracic surgeons, and oncologists to ensure accurate diagnosis, staging, and the development of individualized treatment plans. Emphasizing the latest advancements in imaging techniques, biopsy procedures, molecular testing, oncology, and surgical management, the course will equip participants with the essential skills to accurately assess and treat early-stage lung cancer. This will ensure that patients receive timely, targeted, and effective interventions.
The course aims to deepen participants’ knowledge of both surgical and non-surgical treatment options. This includes minimally invasive techniques, stereotactic body radiotherapy (SBRT), and the role of adjuvant therapies. By incorporating case-based learning and evidence-based guidelines, the course will help foster a patient-centered approach to care. This approach emphasizes the importance of shared decision-making and long-term follow-up for improving patient outcomes. The ultimate goal is to empower physicians to optimize treatment outcomes, reduce recurrence rates, and enhance patient survival and quality of life.

Falcon Workshop on Prostate SBRT by ESTRO
2025-03-20 18:00 - 20:00 (America/Halifax)
Falcon Workshop on Prostate SBRT by ESTRO will be held at March 20 and 27, 2025, Virtually.
This workshop is aimed at those involved in prostate radiotherapy contouring, including trainee oncologists, established oncologists, and contouring radiographers. It focuses on improving contouring accuracy, a key source of error in radiotherapy. The course includes practical contouring exercises, feedback from experts, and guidance on common pitfalls, with examples from the PACE trial’s quality assurance process.
Participants will complete pre-workshop homework and attend two online sessions. In the first, faculty will present guidelines and review initial contours, while in the second, revised contours will be compared to reference contours with feedback provided. CME accreditation is being applied for through EACCME, with credits recognized by the American Medical Association.
